Effects of heme oxygenase-1 upregulation on isoproterenol-induced myocardial infarction

Area of Science:

• Cardiology
• Biochemistry
• Pharmacology

Background:

• Myocardial infarction (MI) is a significant cause of mortality and morbidity.
• Isoproterenol (ISO) is commonly used to induce experimental MI, mimicking pathological changes.
• Heme oxygenase-1 (HO-1) is a stress-inducible enzyme with known cytoprotective properties.

Purpose of the Study:

• To investigate the protective effects of HO-1 induction by cobalt protoporphyrin (CoPP) on ISO-induced myocardial injury.
• To evaluate the impact of CoPP on cardiac function, morphology, ECG, antioxidant status, and specific protein expression.

Main Methods:

• Adult male Sprague Dawley rats were divided into four groups: normal control, ISO-induced MI, ISO + Trizma (vehicle control), and ISO + CoPP.
• Myocardial infarction was induced using intraperitoneal injections of ISO.
• CoPP was administered to induce HO-1, and various cardiac parameters were assessed, including enzyme levels, antioxidant activity (SOD, GSH), and protein expression (HO-1, Hsp70, Cx-43).

Main Results:

• ISO administration led to significant cardiac dysfunction, elevated cardiac enzymes, and altered ECG parameters, alongside increased HO-1 and Hsp70 but decreased SOD and GSH.
• CoPP treatment significantly improved ECG parameters, cardiac enzymes, and morphology in ISO-treated rats.
• CoPP administration resulted in increased myocardial expression of HO-1, Hsp70, and connexin 43 (Cx-43).

Conclusions:

• Induction of HO-1 by CoPP effectively ameliorates ISO-induced myocardial injury.
• The protective mechanism may involve the up-regulation of heat shock protein 70 (Hsp70) and connexin 43 (Cx-43).
• HO-1 induction represents a promising therapeutic avenue for managing myocardial infarction.